Stepwise Strategy for Treatment of Atrialfibrillation Substrate Study — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Stepwise Strategy for Treatment of Atrialfibrillation Substrate Study — Stella

Home/Atrial Fibrillation/

View on ClinicalTrials.gov

Recruiting

Back to Atrial Fibrillation trials

Trial locations(1 site)

China

the second affiliated hospital of CQMU, Chongqing

Key details

Sponsor

Yuehui Yin

Enrollment target

~480 participants

Started

April 2023

Primary completion

November 2024

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 70 Years

Last updated August 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.